Solution structural bundle of bivalirudin - a bivalent hirudin based thrombin inhibitor
SOLUTION NMR
| NMR Experiment | ||||||||
|---|---|---|---|---|---|---|---|---|
| Experiment | Type | Sample Contents | Solvent | Ionic Strength | pH | Pressure | Temperature (K) | Spectrometer |
| 1 | 2D 13C HSQC | 16.67 mg/mL bivalirudin, 20 mM sodium phosphate | 90% H2O/10% D2O | 20 mM | 4.6 | 1 atm | 298 | Bruker AVANCE III 600 |
| 2 | 2D 13C HSQC TOCSY | 16.67 mg/mL bivalirudin, 20 mM sodium phosphate | 90% H2O/10% D2O | 20 mM | 4.6 | 1 atm | 298 | Bruker AVANCE III 600 |
| 3 | 2D 13C HMBC | 16.67 mg/mL bivalirudin, 20 mM sodium phosphate | 90% H2O/10% D2O | 20 mM | 4.6 | 1 atm | 298 | Bruker AVANCE III 600 |
| 4 | 2D 15N HSQC | 16.67 mg/mL bivalirudin, 20 mM sodium phosphate | 90% H2O/10% D2O | 20 mM | 4.6 | 1 atm | 298 | Bruker AVANCE III 600 |
| 5 | 2D 15N HSQC TOCSY | 16.67 mg/mL bivalirudin, 20 mM sodium phosphate | 90% H2O/10% D2O | 20 mM | 4.6 | 1 atm | 298 | Bruker AVANCE III 600 |
| 6 | 2D 1H NOESY | 16.67 mg/mL bivalirudin, 20 mM sodium phosphate | 90% H2O/10% D2O | 20 mM | 4.6 | 1 atm | 298 | Bruker AVANCE III 600 |
| NMR Spectrometer Information | |||
|---|---|---|---|
| Spectrometer | Manufacturer | Model | Field Strength |
| 1 | Bruker | AVANCE III | 600 |
| NMR Refinement | ||
|---|---|---|
| Method | Details | Software |
| simulated annealing | X-PLOR NIH | |
| NMR Ensemble Information | |
|---|---|
| Conformer Selection Criteria | structures with the lowest energy |
| Conformers Calculated Total Number | 100 |
| Conformers Submitted Total Number | 5 |
| Representative Model | 1 (medoid) |
| Computation: NMR Software | ||||
|---|---|---|---|---|
| # | Classification | Version | Software Name | Author |
| 1 | collection | TopSpin | Bruker Biospin | |
| 2 | processing | TopSpin | Bruker Biospin | |
| 3 | chemical shift assignment | Sparky | Goddard | |
| 4 | refinement | X-PLOR NIH | Schwieters, Kuszewski, Tjandra and Clore | |
| 5 | structure calculation | X-PLOR NIH | Schwieters, Kuszewski, Tjandra and Clore | |














